English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, June 19, 2024
Kaplan Fox Files Class Action to Recover Losses for Investors Who Purchased Common Stock of Inari Medical, Inc. (NasdaqGS: NARI) for an Expanded Class Period - March 10, 2021 through February 28, 2024
SCOTTS MIRACLE-GRO (SMG) ALERT: Kaplan Fox & Kilsheimer LLP Reminds Investors of Important August 5, 2024 Lead Plaintiff Deadline in Securities Fraud Class Action
Monday, June 17, 2024
EQIX Shareholder Alert: Kaplan Fox & Kilsheimer LLP Notifies Investors of Class Action Complaint Filing and Deadline
Saturday, June 15, 2024
EQUINIX, INC. (EQIX) ALERT: Kaplan Fox & Kilsheimer LLP Reminds Investors of Important July 1, 2024 Lead Plaintiff Deadline in Securities Fraud Class Action
Wednesday, June 12, 2024
AUTODESK (ADSK) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Reminds Autodesk Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Autodesk
Friday, May 31, 2024
INARI MEDICAL, INC. (NARI) ALERT: Kaplan Fox & Kilsheimer LLP Reminds Investors of Important Deadline in Securities Fraud Class Action
Friday, May 10, 2024
AGILON HEALTH (NYSE: AGL) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Agilon Health Investors of a Class Action Lawsuit and May 20, 2024 Lead Plaintiff Deadline
SSR MINING (SSRM) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies SSR Mining Investors of a Class Action Lawsuit and May 17, 2024 Lead Plaintiff Deadline
CHEMOURS (NYSE: CC) ALERT: Kaplan Fox & Kilsheimer LLP Reminds Investors of Class Action Lawsuit and May 20, 2024 Lead Plaintiff Deadline
DOXIMITY (NYSE: DOCS) ALERT: Kaplan Fox & Kilsheimer LLP Reminds Investors of Class Action Lawsuit and June 17, 2024 Lead Plaintiff Deadline
Kaplan Fox & Kilsheimer LLP Links

https://www.facebook.com/KaplanFoxLawFirm

https://twitter.com/kaplanfoxlaw

https://www.linkedin.com/company/kaplan-fox-&-kilsheimer-llp/

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575